Le Lézard
Classified in: Health, Science and technology, Business

SimplyVital Health Extends Token Pre-sale for Maximum Impact After Cancelled Fork


BLOOMFIELD, Connecticut, Nov. 21, 2017 /PRNewswire/ -- SimplyVital Health, the Connecticut-based company pioneering a new paradigm for information sharing in the medical industry, is extending its token pre-sale in the wake of the recent resolution of the bitcoin fork drama, and to allow further prospective partners the opportunity to explore its business model and Health Nexus platform as a result.

SVH: healthcare-grade blockchain

"The cryptocurrency world has been held in a state of perpetual uncertainty over recent months, as a series of controversial forks have threatened to split the community and network's value," explains SimplyVital Health co-founder and CEO, Kat Kuzmeskas. "There are a number of potential partnerships for Health Nexus that we are pursuing ? as well as a large number of individuals and institutional players in the wider crypto world ? who have been waiting for a resolution before making their next move. Now that the SegWit2x question has been settled, we are optimistic that we'll be able to initiate further partnerships and continue to attract investment. In addition, many potential contributors expressed interest and excitement in Health Nexus and they want to continue conversations before participating, so we want to honor and adapt to those requests. We're very pleased that confidence has returned to the market and have taken the decision to prolong our pre-sale to enable us to explore these opportunities."

Medical data on the blockchain

SimplyVital Health (SVH) was founded to overcome the tensions that exist around data sharing in the medical industry. Whilst ensuring reliable access to patients' medical information is critical for the best outcomes, this data is also highly confidential and its movement subject to stringent regulation. The result is that patient health can become an unintended casualty of data protection law.

Health Nexus, SVH's flagship solution, uses a permissioned blockchain to store and transfer data between nodes. Unlike bitcoin, Ethereum and other open blockchain platforms, every node or 'miner' that maintains the network must be validated, operating within the framework of HIPAA compliance. This means that while the system is highly secure and fit to deal with private healthcare data, patient information can move freely as required, without concerns about unauthorised access. Health Nexus can be integrated with existing healthcare systems for lower on-boarding costs.

HealthCash token

SimplyVital Health is holding a token sale for Health Cash (HLTH), the blockchain token that will power the system by providing rewards to the miners who maintain the network. This will also serve the purpose of attracting newcomers to the ecosystem, helping it to grow and reach critical mass quickly and bringing the exceptional benefits of blockchain technology to a wide range of healthcare providers, and provides additional revenue stream opportunities to healthcare partners.

The SimplyVital Health pre-sale has been extended until 20 February, with the main sale starting on 22 February. To find out more or participate in the token sale, visit https://tokensale.simplyvitalhealth.com/.


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:15
Wolters Kluwer, a global leader in information, software, and services for professionals, today announces that its CCH® Tagetik expert solution has retained its leadership position for the seventh consecutive year in both the Global and DACH region...

at 07:10
D-Wave Quantum Inc., ("D-Wave" or the "Company") a leader in commercial quantum computing systems, software, and services, today announced financial results for its fourth fiscal quarter and year ended December 31, 2023. "Our momentum is...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Zilliant, the leader in pricing lifecycle management, today announced it recently concluded a year of rapid growth, delivering two consecutive quarters of 60%+ growth in year-over-year bookings. The company is positioned for continued record growth...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....



News published on and distributed by: